Inactive Instrument
Radient Technologies Inc. Stock Other OTC
Stocks
RDDTF
CA75034P1062
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.46M 1.26M 1.18M 1.08M 2.03M 140M 2.04M 14M 5.46M 70.49M 5.49M 5.37M 234M | P/E 2021 |
-0.89x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 15.13M 13.04M 12.23M 11.16M 21.03M 1.45B 21.09M 145M 56.6M 730M 56.82M 55.58M 2.42B | EV / Sales 2021 |
22.5x | EV / Sales 2022 | 12.2x |
| Free-Float |
100% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.75% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.75% | +7.99% | - | - | 540 | |
| +0.02% | +1.36% | -13.16% | -6.82% | 13.26B | |
| +0.53% | +2.99% | -31.39% | -57.20% | 4.99B | |
| +0.27% | +1.59% | -5.32% | -1.35% | 4.66B | |
| -0.43% | -1.64% | -1.22% | -30.41% | 4.02B | |
| +0.08% | +3.06% | -20.99% | +4.99% | 3.59B | |
| -0.67% | +2.71% | -2.98% | -5.08% | 3.43B | |
| +0.47% | -0.53% | -9.87% | +6.74% | 3.31B | |
| -2.19% | -2.26% | -22.25% | -14.00% | 2.38B | |
| +0.74% | +2.97% | -26.78% | -13.38% | 1.72B | |
| Average | -0.79% | +1.90% | -14.88% | -12.95% | 4.6B | |
| Weighted average by Cap. | -0.05% | +1.73% | -13.98% | -13.01% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 2.49M 2.15M 2.01M 1.84M 3.46M 238M 3.47M 23.86M 9.31M 120M 9.35M 9.14M 398M | 3.62M 3.12M 2.93M 2.67M 5.03M 346M 5.05M 34.72M 13.55M 175M 13.6M 13.3M 579M |
| Net income | -42.27M -36.42M -34.15M -31.17M -58.72M -4.04B -58.91M -405M -158M -2.04B -159M -155M -6.76B | -12.93M -11.14M -10.45M -9.54M -17.96M -1.24B -18.02M -124M -48.36M -624M -48.55M -47.49M -2.07B |
| Net Debt | 11.44M 9.86M 9.24M 8.44M 15.9M 1.09B 15.95M 110M 42.79M 552M 42.96M 42.02M 1.83B | 13.67M 11.78M 11.05M 10.08M 19M 1.31B 19.06M 131M 51.13M 660M 51.33M 50.22M 2.19B |
Employees
-
Sector
Pharmaceuticals
